M2 macrophages and CXCL13 may activate the Akt pathway in ccRCC lines, and Akt inhibitors decrease ccRCC lines proliferation, migration, invasion, and EMT. The gene discussed is AKT1; the disease is nonpapillary renal cell carcinoma.